Skip to content

PS150 Total Knee Arthroplasty Outcomes Registry

Outcomes of Total Knee Arthroplasty (TKA) Using the Sigma PS150 Primary Total Knee System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02319291
Enrollment
175
Registered
2014-12-18
Start date
2015-02-01
Completion date
2021-11-03
Last updated
2023-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Rheumatoid Arthritis

Brief summary

This registry is intended to evaluate the clinical outcomes of the DePuy P.F.C. Sigma PS150 RP Total Knee System. 200 participants will be enrolled prospectively or retrospectively and the follow up period will be 5 years. Data collection will include Radiographic Analysis, Knee Society Evaluation and Adverse Events.

Interventions

DEVICEP.F.C. Sigma PS150 RP Total Knee System

Total Knee Arthroplasty - surgical procedure to replace knee with metal implant

Sponsors

DePuy Orthopaedics
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Primary total knee replacement for any indication in accordance with the Instructions For Use accompanying the SIGMA PS150 implant. * Signed Informed Patient Consent

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frameDescription
Implant Survivorship5 yearsLack of revision with revision meaning no removal or replacement of any TKA component.

Secondary

MeasureTime frameDescription
Knee Society Score - Knee Score1, 3 & 5 yearsDescriptive statistics, including change from baseline (post-op minus pre-op)
Knee Society Score - Function1, 3 & 5 yearsDescriptive statistics, including change from baseline (post-op minus pre-op)
Pain sub-question of the Knee Society Score1, 3 & 5 yearsDescriptive statistics, including change from baseline (post-op minus pre-op)
Flexion1, 3 & 5 yearsDescriptive statistics, including change from baseline (post-op minus pre-op)
Extension1, 3 & 5 yearsDescriptive statistics, including change from baseline (post-op minus pre-op)
Radiographic Analysis1, 3 & 5 yearsDescriptive statistics
Adverse Events1, 3 & 5 yearsType and frequency of adverse events

Countries

Australia, South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026